Rocket Pharmaceuticals Inc (RCKT)

Finanzdaten der Rocket Pharmaceuticals Inc-Aktie (RCKT)

Gewinn- und Verlustrechnung

Vierteljährlich

*Alle Zahlen in Millionen

Enddatum des Zeitraums	2024-03-31	2023-12-31	2023-09-30	2023-06-30	2023-03-31
Periodenlänge	3 Monate	3 Monate	3 Monate	3 Monate	3 Monate
Revenues	-	-	-	-	-
Operating Expenses	6.47% 67.38	63.28	65.43	68.76	62.19
Interest Income/Expense	0.21% 0.471	0.47	0.469	0.468	0.468
Operating Income/Loss	6.47% -67.38	-63.28	-65.43	-68.76	-62.19
Income/Loss From Continuing Operations Before Tax	4.01% -62.05	-59.66	-61.90	-65.70	-58.34
Income/Loss From Continuing Operations After Tax	4.01% -62.05	-59.66	-61.90	-65.70	-58.34
Net Income/Loss	4.01% -62.05	-59.66	-61.90	-65.70	-58.34
Preferred Stock Dividends And Other Adjustments	-	-	-	-	-
Attributable To Noncontrolling Interest	-	-	-	-	-
Basic Average Shares	2,876% 93.55	3.1433	82.64	80.47	79.45
Diluted Average Shares	2,876% 93.55	3.1433	82.64	80.47	79.45
Basic Earnings Per Share	6.45% -0.66	-0.62	-0.75	-0.82	-0.73
Diluted Earnings Per Share	6.45% -0.66	-0.62	-0.75	-0.82	-0.73
Participating Securities, Distributed And Undistributed Earnings/Loss, Basic	-	-	-	-	-